Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Fundraising > Increase Your Chances of Repeat-Funding By Staying In Touch With Grant Makers

Tags

  • devices
  • challenges
  • product
  • combination products
  • companies involved

  • Links

  • Buying a Home: Preparing for Home Ownership
  • What is Hearing Loss?
  • Charming Trends in Dog Jewelry
  • Digg It - Increase Your Chances of Repeat-Funding By Staying In Touch With Grant Makers

    When a grant is approved, you should read your award letter as caref
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ully as you did the application before you applied because the lette
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    should outline how often the Funder expects to hear from you. Read
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    hrough it and find out how many formal reports they expect from you.
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    If you are unsure, contact them and ask. Many will ask for a mid-poi
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    t and final report. Even if they don’t ask for these two reports, it
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    is a good idea to send them a letter with a brief update about the
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    rogress of your project, in order to stay in touch.

    If any signific
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    nt program changes occur, for example, a shift in your budget or maj
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    r delays in the outlined timeline you will need to contact the Funde
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    and let them know. If the change is major and shifts the way that y
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ou will be spending the grant, you will need to get their prior appr
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    val.

    In addition, think of sharing any good news about your project
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    that is noteworthy. For example, if you are featured in the local pr
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ss, clip the article and pass it along to the funder. If you have a
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ompelling success story from a program participant, type it up, incl
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    ude a photo and send it to the funder. Sharing good news with funder
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    is important for two reasons: 1) you are building a relationship wi
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    h them, showing them your appreciation of their investment in your p
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    oject, and 2) you are making it really easy for them to invest again


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/19708/diggit-Increase-Your-Chances-of-RepeatFunding-By-Staying-In-Touch-With-Grant-Makers.html">Increase Your Chances of Repeat-Funding By Staying In Touch With Grant Makers</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/19708/diggit-Increase-Your-Chances-of-RepeatFunding-By-Staying-In-Touch-With-Grant-Makers.html]Increase Your Chances of Repeat-Funding By Staying In Touch With Grant Makers[/url]

    Related Articles:

    The Business of Art Workshops: Creating Your Own Job Security

    S Corporation Requirements

    Millionaire Mind: How to Think like a Millionaire - Be a Millionaire

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com